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 Introduction 
 C-Met overexpression correlates closely with metastatic tendency 
and poor prognosis ( Trusolino and Comoglio, 2002 ;  Birchmeier 
et al., 2003 ). In addition, several germline and somatic missense 
mutations of c-Met, which lead to increased tyrosine kinase ac-
tivity, have been reported in various tumors ( Graveel et al., 2005 ). 
Hence, c-Met is an attractive molecular target for cancer therapy 
( Christensen et al., 2005 ). 
 The oncogene signal transducer and activator of transcrip-
tion 3 (STAT3) acts downstream of c-Met to control c-Met – 
dependent tubulogenesis ( Boccaccio et al., 1998 ), wound healing 
( Sano et al., 1999 ), invasion ( Cramer et al., 2005 ), anchorage-
independent growth, and tumorigenic growth in nude mice 
( Zhang et al., 2002 ). HGF was reported to stimulate STAT3 
 recruitment to c-Met at the plasma membrane, its phosphory-
lation on tyrosine 705, nuclear translocation, and binding to the 
specifi c promoter element Sis-inducible element ( Boccaccio 
et al., 1998 ). Because the biological effect of STAT transcrip-
tional activity requires entry into the nucleus, cytoplasmic-
 nuclear translocation of STAT proteins is crucial ( Reich and Liu, 
2006 ). Although endosomal transport has recently been pro-
posed as a possible requirement ( Bild et al., 2002 ;  Howe, 2005 ; 
 Shah et al., 2006 ), the current favored model of STAT3 response 
to stimuli is free cytosolic diffusion from the plasma membrane 
to the nucleus. 
 Increasing awareness of the importance of compartmen-
tal signaling of cell surface receptors ( Miaczynska et al., 2004 ; 
 Kholodenko, 2006 ;  Polo and Di Fiore, 2006 ) and downstream sig-
naling and effectors, as recently shown for Akt pathway ( Schenck 
et al., 2008 ), questions whether a diffusion model is correct. It has 
been shown previously that c-Met signals emanate not only from 
the plasma membrane but also from endosomal compartments 
( Kermorgant et al., 2004 ;  Kermorgant and Parker, 2005 ). It is 
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(EEA1) – positive endosomes ( Fig. 1, C and D ), indicating that 
STAT3 can access the active, traffi cking receptor. 
 STAT3 and extracellular signal-regulated 
kinase (ERK) 1/2 nuclear accumulation 
upon HGF stimulation is dependent on 
c-Met endocytosis 
 Perturbation of the endocytic machinery either by knocking 
down clathrin heavy chain (CHC) or by expressing myc-AP180C 
or by treating cells with concanavalin A have been reported pre-
viously to block c-Met internalization (Fig. S1, D and E; and 
Fig. S2 A;  Kermorgant et al., 2004 ). Blockade is also observed 
with dynasore, a recently described cell-permeable inhibitor of 
dynamin ( Fig. 2, C and D ;  Macia et al., 2006 ). Confi rmation of 
receptor endocytosis impairment in cells treated by dynasore 
and/or transfected by myc-AP180C was performed by measur-
ing cellular uptake of fl uorescently tagged transferrin and HGF 
(Fig. S1, C – F). 
 It was detected that HGF/c-Met – dependent STAT3 and 
also ERK1/2 nuclear accumulation are impaired signifi cantly 
when c-Met endocytosis is inhibited ( Fig. 2, A – H ). However, 
receptor traffi c is not a universal requirement because dynasore 
or expression of myc-AP180C does not impair the cytokine on-
costatin M – induced STAT3 nuclear accumulation ( Fig. 2, C, 
E, and F ). Thus, although the oncostatin M receptor has been 
reported to become internalized ( Heinrich et al., 2003 ), STAT3 
nuclear delivery, upon stimulation with this cytokine, appears to 
demonstrated here that STAT3 activation and nuclear accumulation 
in response to HGF requires nuclear-proximal activated c-Met. 
 Results and discussion 
 C-Met and STAT3 colocalize on endosomes 
before STAT3 nuclear accumulation 
 In HeLa cell cultures, STAT3 is localized in the cytoplasm 
( Fig. 1 A and Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200806076/DC1) but can be present to a vari-
able extent in the nucleus (Fig. S1 A, top). This distribution 
is likely the consequence of continuous shuttling under basal 
conditions ( Pranada et al., 2004 ;  Liu et al., 2005 ). Stimulation 
with hepatocyte growth factor (HGF) for 120 min leads to a 
signifi cant increase in nuclear accumulation of STAT3 ( Fig. 1, 
A and B ; and Fig. S1 A). The STAT3 nuclear accumulation 
on HGF stimulation correlates with a strong nuclear signal for 
STAT3 phosphorylated on tyrosine 705 (Fig. S1 B). These re-
sults indicate that, according to current models, nonphosphory-
lated STAT3 undergoes nuclear-cytoplasm shuttling under basal 
conditions and that HGF stimulates phosphorylated STAT3 nu-
clear accumulation. 
 C-Met rapidly internalizes through the clathrin pathway 
and then further traffi cs from endosomes to a nondegradative 
perinuclear endosomal compartment ( Kermorgant et al., 2003 ). 
During its intracellular traffi cking, c-Met colocalizes with pan-
STAT3 and phospho-STAT3 on early endosome autoantigen 1 
 Figure 1.  C-Met and STAT3 colocalize on 
endosomes. (A) Confocal sections of HeLa 
cells stimulated with HGF for 0 or 120 min 
and stained for STAT3 and DAPI. Bars, 20  μ m. 
(B) Quantitation of STAT3 nuclear-cytoplasmic 
ratios (STAT3 N/C ratio) at 0 or 120 min of 
HGF stimulation. Statistical analyses of ﬁ ve in-
dependent experiments are presented as box 
and whiskers plots (see Statistical analysis of 
confocal images). The mean values are on top 
of each box. ***, P  < 0.0001. (C) Cells stimu-
lated with HGF for 10 or 30 min were stained 
for STAT3, c-Met, and DAPI. Confocal sections 
are shown. Bars, 20  μ m. (D) Cells stimulated 
with HGF for 10 min were stained for P-STAT3 
(Y705), c-Met, DAPI, and EEA1. Confocal sec-
tions are shown. White boxes deﬁ ne the en-
larged areas shown at the right. Bars, 10  μ m. 
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Consistent with this and with our immunofl uorescence data 
(Fig. S1 B), it was observed by Western blot that, in parallel to 
the nuclear accumulation, STAT3 was phosphorylated on Y705 
after 2 h ( Fig. 2 I ), which is indicative of a role for tyrosine 
phosphorylation in nuclear accumulation. In addition, when the 
endocytic machinery was perturbed through CHC knockdown, 
dynasore, or concanavalin A treatment, STAT3 Y705 and ERK1/2 
phosphorylation were inhibited ( Fig. 2, I and J ; and Fig. S2 C), 
thus mirroring the loss of nuclear STAT3 and ERK1/2. C-Met 
be independent of the endocytic machinery. This is consistent 
with the previous fi ndings ( Heinrich et al., 2003 ). The distinc-
tive responses to HGF and oncostatin M indicate that STAT3 
delivery to the nucleus can operate through distinct mecha-
nisms in the same cell. STAT3 Y705 phosphorylation was re-
ported not to play a role in STAT3 cytoplasmic-nuclear shuttling 
under basal conditions ( Pranada et al., 2004 ;  Liu et al., 2005 ), 
although it was reported to control STAT3 nuclear accumulation 
upon cytokine or growth factor stimulation ( Liu et al., 2005 ). 
 Figure 2.  STAT3 and ERK1/2 nuclear accu-
mulation is dependent on c-Met endocytosis. 
In A and B, HeLa cells transfected with con-
trol or CHC RNAi were treated by HGF for 
0 or 120 min. (A) Confocal projections of cells 
stained for STAT3 and DAPI. Bars, 20  μ m. 
(B) Quantitation of STAT3 nuclear-cytoplasmic 
ratios (STAT3 N/C ratio). ***, P  < 0.0001. 
(C) Cells incubated in 80  μ M dynasore were not 
stimulated or stimulated with HGF for 120 min 
or oncostatin M for 30 min. Confocal sections of 
cells stained for STAT3 and DAPI. Bars, 20  μ m. 
(D) Quantitation of STAT3 nuclear-cytoplasmic 
ratios. (E) Confocal projections of ﬁ ve Z sections 
of cells transfected (T) or not (NT) with myc-
AP180C and stained with STAT3, Myc, and 
DAPI after 120 min of stimulation with HGF 
or oncostatin M. Bars, 20  μ m. (F) Quantitation 
of STAT3 nuclear intensity in Myc-AP180C T 
versus NT. The graphs show the nuclear STAT3 
accumulation expressed as a ratio (T/NT) for 
myc-AP180C transfected versus nontransfected 
cells. The columns are mean values and the 
error bars are SD. An unpaired  t test was per-
formed. *, P  < 0.01. (G) Cells were stimulated 
with HGF for 0 and 120 min in the absence 
or presence of 80  μ M dynasore. Confocal 
sections of cells stained for ERK1/2 and DAPI 
are shown. Bars, 20  μ m. (H) Quantitation of 
ERK1/2 nuclear-cytoplasmic ratios. ***, P  < 
0.0001. (I and J). Cells were treated by HGF 
for 0 or 120 min. Western blots for CHC, phos-
phorylated STAT3 (Y705), pan-STAT3, phos-
phorylated c-Met (tyrosine 1349), pan – c-Met 
and phosphorylated ERK1/2. The numbers 
represent fold increase of P-STAT3/STAT3 or 
P-STAT3/tubulin and P-ERK/tubulin ratios be-
tween HGF for 120 and 0 min obtained by den-
sitometry in three independent experiments. 
(I) Cells were transfected with control or CHC 
RNAi. (J) Cells were treated or not by 80  μ M 
dynasore. Molecular masses are shown in kD. 
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Overexpression of p50/dynamitin, which was previously shown 
to block dynein-dependent endosomal movements along the 
microtubules in HeLa cells ( Burkhardt et al., 1997 ), also im-
paired HGF-dependent STAT3 nuclear accumulation ( Fig. 3 E 
and Fig. S2 E). Similar results were obtained in HeLa cells 
knocked down for PKC  (Fig. S2, F – H) and in PKC  knockout 
mouse fi broblasts ( Fig. 3 F ). It can be concluded that c-Met di-
rectional traffi cking from the peripheral endosomal compart-
ment toward the perinuclear endosomal compartment is required 
for HGF/c-Met to maintain STAT3 nuclear accumulation. Simi-
larly, it was described previously that the nerve growth factor –
 dependent transport of ERK5 from distal axons to the cell body 
and further translocation to the nucleus required endocytosis 
and microtubule transport ( Ginty and Segal, 2002 ). For HGF/
c-Met, the process would appear to be dynamic with constant 
dissociation and reassociation of STAT3 with activated c-Met 
endosomal complexes, with the steady-state phosphorylation be-
ing determined by the c-Met activity/phosphotyrosine phospha-
tase balance. This behavior would appear to be receptor specifi c 
because we show that oncostatin M – dependent nuclear uptake 
of STAT3 does not require receptor endocytosis and microtubule 
integrity. The kinase/phosphatase balance here is clearly different. 
Interestingly, HGF/c-Met – dependent ERK1/2 nuclear accumula-
tion was not blocked by microtubule disruption ( Fig. 3, G and H ), 
phosphorylation was also reduced under these conditions ( Fig. 2 J 
and Fig. S2 C;  Kermorgant et al., 2004 ). These results indicate 
that to sustain their phosphorylation, STAT3 and ERK1/2 re-
quire c-Met endocytosis as well as the maintainance of active 
c-Met. This response to the blockade of c-Met endocytosis was 
specifi c to the Y705 input to STAT3 because the serine 727 phos-
phorylation induced by HGF was unaffected (unpublished data). 
 STAT3, but not ERK1/2, nuclear 
accumulation upon HGF stimulation 
is dependent on c-Met trafﬁ cking 
to a perinuclear localization 
 It was shown previously that c-Met traffi cs from a peripheral 
endosomal compartment to a perinuclear endosomal compart-
ment along the microtubule network and that this is facilitated 
by PKC  catalytic activity ( Kermorgant et al., 2003 ). PKC  in-
hibition by G ö 6976 (but not inhibition after c-Met traffi c; see 
 Fig. 4, A and B ), or microtubule disruption by vinblastine, led 
to a reduction of HGF/c-Met – dependent STAT3 nuclear accu-
mulation ( Fig. 3, A – C ; and Fig. S2 D). This paralleled the per-
turbation in c-Met traffi c, which showed a decrease in perinuclear 
endosomal c-Met and sustained peripheral endosomal c-Met 
( Fig. 3 A , right). In contrast to HGF, vinblastine did not block 
oncostatin M – dependent STAT3 nuclear accumulation ( Fig. 3 D ). 
 Figure 3.  STAT3, but not ERK1/2, nuclear 
accumulation is promoted by c-Met microtubule-
dependent trafﬁ c. (A) HeLa cells stimulated 
with HGF for 0 or 120 min alone or in the 
presence of 1  μ M G ö 6976 or 1  μ M vinblas-
tine were stained for STAT3 and c-Met. Confo-
cal sections are shown. Bars, 20  μ m. (B and C) 
Quantitation of STAT3 nuclear-cytoplasmic 
ratios (STAT3 N/C ratio). ***, P  < 0.0001. 
(D) Quantitation of STAT3 nuclear-cytoplasmic 
ratios under oncostatin M stimulation for 
0 and 120 min in presence of 1  μ M vinblas-
tine. ***, P  < 0.0001 (pictures not shown). 
(E) Cells were transfected with myc-dynamitin 
and stained with STAT3, Myc, and DAPI af-
ter 120 min of stimulation with HGF. The plot 
represents the quantitation of STAT3 nuclear-
cytoplasmic ratios in nontransfected and trans-
fected cells. ***, P  < 0.0001 (Fig. S2 E [pictures], 
available at http://www.jcb.org/cgi/content/
full/jcb.200806076/DC1). (F) Confocal 
projections of PKC  knockout or wild-type 
mouse embryo ﬁ broblasts, stained for STAT3 
and DAPI. Bars, 20  μ m. (G) Quantitation of 
ERK1/2 nuclear-cytoplasmic ratios in cells stimu-
lated with HGF for 0 or 120 min in the absence 
or presence of 1  μ M vinblastine. (H) Confo-
cal section of ERK1/2 nuclear localization 
and endosomal c-Met in cells stimulated with 
HGF and vinblastine for 120 min. Bar, 20  μ m. 
(I) Cells were stimulated with HGF for 0, 30, 
or 120 min in the absence or presence of 
1  μ M vinblastine. Western blots for phosphory-
lated STAT3 (Y705), tubulin, and phosphory-
lated ERK1/2. Molecular masses are shown 
in kD. (J) Densitometric analysis of I. The bars 
represent fold increase of P-STAT3/tubulin and 
P-ERK/tubulin ratios between HGF for 120 
and 0 min obtained by densitometry in three 
independent experiments. Error bars repre-
sent SEM. 
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phosphorylation. K252a addition after treatment (i.e., added for 
the last 5 min of a 120-min HGF stimulation) also inhibited 
c-Met phosphorylation ( Fig. 4 C and Fig. S2 I). Addition after 
treatment with the neutralizing anti-HGF antibody had no effect 
( Fig. 4 C and Fig. S2 J). The effectiveness of acute exposure 
with the anti-HGF antibody was confi rmed (Fig. S2 J). At 115 min 
of HGF treatment, c-Met had fully internalized and traffi cked 
to the perinuclear compartment ( Fig. 3 A , right, second from 
the top) and was not accessible to the neutralizing antibodies 
but remained accessible to the membrane-permeable inhibitor 
K252a. Similar results were obtained with the c-Met inhibitor 
SU-11274 (unpublished data). These results demonstrate that 
HGF-dependent STAT3 accumulation in the nucleus requires 
the retention of the c-Met perinuclear pool in an active state. 
 HGF triggers a weak STAT3 signal but 
a strong ERK1/2 signal 
 STAT3 pathway stimulation by HGF was further compared with 
oncostatin M stimulation to assess why distinct mechanisms might 
be required for signal delivery to the nucleus. STAT3 showed no 
signifi cant increase in phosphorylation or nuclear accumulation 
on acute (15 and 30 min) HGF treatment. This is not a cell-
 specifi c idiosyncrasy because in the same model oncostatin M 
elicited strong responses ( Fig. 5, A – C and E – I ). This indicates 
which is indicative of both a functional endosomal c-Met and dis-
tinctive spatial constraints exerted on ERK1/2 activation. Con-
sistent with this, microtubule disruption inhibited HGF-dependent 
STAT3 but not ERK1/2 phosphorylation ( Fig. 3, I and J ). 
 STAT3 nuclear accumulation upon HGF 
stimulation requires active endosomal 
c-Met 
 To asses whether maintenance of c-Met activity in endosomal 
compartments is necessary for HGF-dependent STAT3 nuclear 
accumulation, cells were treated with the inhibitor K252a, which 
has been previously shown to inhibit c-Met phosphorylation 
( Coltella et al., 2003 ). Cells were stimulated by HGF for 120 min 
alone or in the presence of K252a, added after 30 min or 
only for the last 5 min of this treatment, and STAT3 localization 
was analyzed by confocal microscopy ( Fig. 4 A ). The STAT3 
nuclear-cytoplasmic ratio signifi cantly decreased from 3.7 to 1.7 
and 2.9 (P  < 0.0002) upon addition of K252a at 30 and 115 min, 
respectively ( Fig. 4, A and B ). In contrast, when a neutralizing 
HGF antibody was added instead of K252a, the nuclear-cyto-
plasmic ratio was unchanged ( Fig. 4, A and B ), which is indicative 
of a lack of requirement for recycling and reactivation of the re-
ceptor. Preincubation with K252a or the neutralizing anti-HGF 
antibody before HGF stimulation for 15 or 120 min blocked c-Met 
 Figure 4.  STAT3 nuclear accumulation is controlled by c-Met 
activation in endosomal compartments. (A) Confocal projec-
tions of cells stained for STAT3. Cells were stimulated for 120 
min with HGF alone or in the presence of K252a or a neutral-
izing anti-HGF antibody or 1  μ M G ö 6976, added at 30 or 
115 min, i.e., 90 or 5 min before ﬁ xation. Bars, 20  μ m. 
(B) Quantitation of STAT3 nuclear-cytoplasmic ratios (STAT3 N/C 
ratio). ***, P  < 0.0002. (C) Phospho – c-Met/tubulin ratios 
obtained by densitometric analysis of Western blots shown 
in Fig. S2 (I and J, available at http://www.jcb.org/cgi/
content/full/jcb.200806076/DC1). Cells were stimulated 
with HGF for the times shown. 1  μ M K252a or 30  μ g/ml of 
a neutralizing HGF antibody was added for 0 or 140 min or 
for the ﬁ nal 5 min of HGF stimulation (5*). The graph repre-
sents the mean of two independent experiments. Error bars 
represent ranges. 
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 Figure 5.  HGF triggers a weak STAT3 signal but a strong ERK1/2 signal. (A) HeLa cells were stimulated for 0, 15, or 120 min with HGF or oncostatin M. 
Western blot for P-STAT3 (Y705), tubulin, and P-ERK1/2. Molecular masses are shown in kD. (B) Densitometric analysis. The graphs represent the fold 
increases of P-STAT3/tubulin and P-ERK1/2/tubulin between stimulated and control and is the mean of three and two independent experiments for HGF 
and oncostatin M stimulation, respectively. Error bars represent SEM. (C) Quantitation of STAT3 nuclear-cytoplasmic ratios (STAT3 N/C ratio) at 0 and 
15 min of stimulation with HGF or oncostatin M . **, P  < 0.001 (pictures not shown). (D) Quantitation of ERK1/2 nuclear-cytoplasmic ratios at 0 and 
30 min of stimulation with HGF. **, P  < 0.001 (pictures not shown). (E) Cells were stimulated or not with HGF with or without 80  μ M dynasore and 400  μ M 
vanadate for the times indicated. Western Blot for P-c-Met (Y1349), P-STAT3 (Y705), tubulin, and P-ERK1/2. The graph represents P-STAT3/tubulin ratios 
obtained by densitometric analysis of three independent experiments. Molecular masses are shown in kD. *, P  < 0.05. Error bars represent SEM. (F) Cells 
stimulated for the times indicated with HGF alone or in the presence of 80  μ M dynasore and 400  μ M vanadate were stained for STAT3 and DAPI. Confocal 
sections are shown. Bars, 20  μ m. (G) Quantitation of STAT3 nuclear-cytoplasmic ratios. ***, P  < 0.0001. (H) Confocal projections of ﬁ ve Z sections of cells 
with or without myc-AP180C and stained with STAT3, myc, and DAPI after 30 min of stimulation with vanadate alone (top) or with HGF (bottom). Bars, 20  μ m. 
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(I) Quantitation of STAT3 nuclear-cytoplasmic ratios. ***, P  < 0.0001. (J) Quantitation of wound closure. The graph is the mean of two independent ex-
periments performed in duplicate. Error bars represent SD. (K) Model of c-Met and oncostatin M receptor stimulation of STAT3 nuclear accumulation. PM, 
plasma membrane; En, peripheral endosome; PN, perinuclear endosome; N, nucleus. At the perinuclear location, the proximity of c-Met with the nucleus 
protects STAT3 against phosphatase activity, allowing a signiﬁ cant increase in nuclear accumulation. 
 
that STAT3 can behave differently for distinct agonists. The de-
layed STAT3 response to HGF was signal specifi c because 
ERK1/2 showed a signifi cant increase in phosphorylation 
under these conditions and nuclear accumulation of ERK1/2 
was observed by 30 min of HGF stimulation ( Fig. 5 D ) when 
STAT3 was still absent ( Fig. 5, A and B ). 
 The different mechanisms of signal accumulation in the 
nucleus might refl ect signal strength associated with distinct tyro-
sine kinase activation and phosphorylation of the signaling mol-
ecule. Thus, we hypothesized that despite the opposing action of 
phosphatases, the strength of STAT3 activation upon oncostatin 
M stimulation and of ERK1/2 activation on HGF stimulation 
are above a threshold that allows diffusion and nuclear uptake. 
By comparison, the activation of STAT3 in response to HGF is 
below the threshold set by phosphatases, and STAT3 is only ef-
fectively phosphorylated and accumulates in the nucleus upon 
delivery of activated c-Met to the perinuclear compartment, lim-
iting exposure to STAT3 protein tyrosine phosphatases. Consis-
tent with this, a 30-min treatment with HGF in the presence of the 
phosphatase inhibitor vanadate on cells pretreated with dynasore 
or concanavalin A triggered STAT3 phosphorylation and nuclear 
accumulation to a level comparable with 120 min of treatment 
with HGF alone ( Fig. 5, E – G ; and Fig. S3, A – D, available at 
http://www.jcb.org/cgi/content/full/jcb.200806076/DC1). Simi-
lar effects of vanadate were obtained in cells transfected with 
mycAP180C ( Fig. 5, H and I ) or pretreated with vinblastine 
(Fig. S3, E and F). 
 HGF-dependent wound healing of STAT3  /  keratino-
cytes has been shown to be impaired in vitro ( Sano et al., 1999 ). 
To assess the STAT3 requirement in this study, wound healing 
experiments were performed. STAT3 localization was fi rst ana-
lyzed in fi xed HeLa cells at the leading edge of the wound. The 
nuclear-cytoplasmic ratio was increased signifi cantly in migrat-
ing cells cultured in the presence of HGF as compared with the 
less motile cells cultured without HGF (Fig. S3, G and H). This 
suggested that STAT3 nuclear accumulation plays a role in HGF-
dependent wound healing. It was found that HGF increased the 
wound closure of HeLa cells by twofold after 24 h ( Fig. 5 J and 
Fig. S3 I). Incubation of cells with the recently described STAT3-
selective inhibitor STA-21 ( Song et al., 2005 ) blocked HGF-
dependent wound closure. The inhibition was HGF specifi c and 
toxicity of the compound was excluded because, under basal 
conditions, STA-21 had no effect on wound healing ( Fig. 5 J 
and Fig. S3 I). STA-21 has been reported to inhibit STAT3 nu-
clear translocation ( Song et al., 2005 ) and this was verifi ed in 
this study (Fig. S3 J). It can be surmised that HGF-dependent 
HeLa cell wound healing is dependent on the STAT3 pathway 
and specifi cally on STAT3 nuclear uptake driven by the endo-
somal traffi c of c-Met. 
 This study shows that HGF-dependent STAT3 transloca-
tion to the nucleus requires c-Met delivery to the perinuclear 
compartment and is not triggered by plasma membrane phos-
phorylation and simple diffusion away from the activated c-Met. 
In contrast, oncostatin M, in the same cells, triggers nuclear 
accumulation of STAT3 independent of endocytosis. C-Met endo-
cytosis is required for both ERK1/2 and STAT3 nuclear accu-
mulation. However, although endocytosis alone is suffi cient to 
support ERK1/2 nuclear accumulation, STAT3 accumulation re-
quires microtubule traffi c of c-Met to the perinuclear compart-
ment. It is proposed that signal strength determines the nuclear 
proximity required for signal delivery. Thus, for a very strong 
signal as observed for oncostatin M – stimulated STAT3, suffi -
cient phosphorylation occurs for an appropriate threshold to be 
reached permitting diffusion through a phosphatase-rich envi-
ronment to reach and accumulate in the nucleus as a phospho-
protein. In contrast, it is proposed that the much weaker signal 
from c-Met to STAT3 requires the signal from the receptor itself 
to be juxtanuclear for the same threshold to be achieved, leading 
to STAT3 accumulation in the nucleus ( Fig. 5 K , model). This is 
consistent not only with the requirement for endocytosis, but also 
for the subsequent traffi c of the activated receptor to the peri-
nuclear compartment to trigger/maintain an increase in nuclear 
STAT3. This insight into agonist action demonstrates that it is 
not simply the receptor and immediate adaptors and effectors 
that determine cellular responses but also the receptor location 
determined by the regulated traffi c of the receptor. This traffi c 
and the subsequent accumulation of nuclear STAT3 are evidently 
critical to HGF-induced migratory responses. 
 Materials and methods 
 Growth factor, antibodies, inhibitors and constructs 
 Puriﬁ ed human recombinant HGF was obtained from R & D Systems and 
 oncostatin M from EMD. Transferrin conjugated to cy-3 was obtained from 
Jackson ImmunoResearch Laboratories. Alexa Fluor 555 Microscale Pro-
tein Labeling kit was used to label HGF according to the manufacturer ’ s in-
structions. The following antibodies were used: goat polyclonal neutralizing 
anti-HGF (Sigma-Aldrich), goat polyclonal neutralizing anti – c-Met, mono-
clonal anti – human c-Met extracellular domain (clone DO24; Millipore), 
goat polyclonal anti-EEA1 (Santa Cruz Biotechnology, Inc.), and mouse 
monoclonal anti-tubulin (Sigma-Aldrich). Rabbit polyclonals used were the 
following: anti – phospho – c-Met (Tyrosine 1349 or Tyrosine 1234/1235), 
pan-ERK, phospho-p42/p44 ERK, mouse monoclonal anti – pan-STAT3, 
phospho-STAT3 (Y706; S727), PKC  (BD Biosciences), anti – pan-STAT3, 
and chc (Santa Cruz Biotechnologies, Inc.). The secondary antibodies 
used for Western blot were peroxidase-labeled monkey anti – mouse or 
anti – rabbit IgG (GE Healthcare). The secondary antibodies used for immuno-
ﬂ uorescence experiments were Alexa 488 – conjugated goat anti – rabbit 
IgG (Invitrogen), cy3-conjugated afﬁ nity-puriﬁ ed donkey anti – mouse IgG, 
and cy5-conjugated afﬁ nity-puriﬁ ed donkey anti – goat IgG (Jackson Immuno-
Research Laboratories). G ö 6976 and vinblastine sulfate were obtained 
from EMD. K252a was obtained from Invitrogen. Vanadate, concanavalin A, 
and dynasore were obtained from Sigma-Aldrich. The pCMV-Myc 
r-AP180 C terminus (residues 530 to 915; myc-AP180-C) construct was a 
gift from H. McMahon (Neurobiology Division, Laboratory of Molecular 
Biology, Cambridge, England, UK). The pCMV-myc-dynamitin construct 
was obtained from C.J. Echeverri (Cenix Bioscience GmbH, Dresden, Ger-
many;  Burkhardt et al., 1997 ). 
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not match any known sequence. Cells were plated at 10 5 per well or 5  × 
10 4 per well in six-well or 24-well plates, respectively. They were trans-
fected the next day in medium without serum using oligofectamine (Invitro-
gen) with 10 or 2  μ l of 20  μ M RNAi and 5 or 1  μ l of transfection reagent 
per well for 6- and 24-well plates, respectively. 10% of serum was added 
4 h later. The cells were stimulated and harvested after 72 h. 
 Wound-healing assays 
 Conﬂ uent cells, deprived for 24 h in 0.5% FBS, were wounded with a pi-
pette tip to obtain one or two perpendicular wounds in each well. The cul-
tures were rinsed once and fresh medium was added with or without HGF 
and with or without drugs as indicated in ﬁ gure legends. Images were ac-
quired on a microscope (Axiovert TM 135; Carl Zeiss, Inc.) equipped with 
a 5 objective lens and a charge-coupled device camera (Orca ER; Hama-
matsu Photonics) using Acquisition Manager (Kinetic Imaging) in the same 
area of each wound at time 0 and 24 h. For each picture, cell areas were 
measured as pixels using Photoshop CS2 (Adobe), and wound closure was 
calculated by subtracting the cell area at 24 h from the cell area at 0 h for 
each wound. 
 Online supplemental material 
 Fig. S1 shows STAT3 and P-STAT3 nuclear accumulation upon HGF stimula-
tion and controls/quantitations for the c-Met endocytosis block. Fig. S2 
shows the effect of concanavalin A on STAT3 nuclear accumulation and 
phosphorylation, tubulin cytoskeleton disruption under vinblastine treat-
ment, lack of STAT3 nuclear accumulation in myc-dynamitin – transfected 
cells, decrease of STAT3 nuclear uptake in cells knocked down for PKC  
and effects of K252a or a neutralizing anti-HGF antibody on c-Met phos-
phorylation. Fig. S3 shows the effect of vanadate on HGF-dependent 
STAT3 phosphorylation and nuclear accumulation when c-Met is main-
tained at the plasma membrane or in the endosome (upon concanavalin A 
or vinblastine treatment, respectively) and implication of STAT3 pathway in 
HGF-dependent wound healing. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200806076/DC1. 
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